Health
New partnership aims to advance predictive tests for multiple myeloma in Ireland – News-Medical.Net
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma, the second most common blood cancer in Ireland.
By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma (MM), the second most common blood cancer in Ireland.
The study will be carried out at Beaumont Hospital Dublin and run through the Blood Cancer Network Ireland with several other cancer hospitals in Ireland participating. It represents a collaboration between RCSI University of Medicine and Health Sciences and SkylineDx with fun…
-
Noosa News13 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News11 hours agoTeenage girl dies in hit-and-run, police hunt for ute
-
Noosa News6 hours ago‘Beyond devastated’ Brisbane family learn missing German shepherd Arnie found dead in back of stolen car
-
Noosa News6 hours agoArnie the dog found dead in stolen ute after week of searching